Skip to main content

Market Overview

Collectar Biosciences Prices $7.0 Million Public Issue


Collectar Biosciences Inc (NASDAQ: CLRB) revealed it priced $7.0 million gross proceeds of its public issue. The company has priced its shares at $2.13 a share along with the traditional warrants. According to the company, the net proceeds of the issue would be about $6.2 million after excluding commissions and estimated expenses.

Collectar Biosciences indicated that for each share or pre-funded warrant purchased, the company would offer an investor a five-year traditional warrant exercisable for one share of its common stock, at $3.04 per share. The company stated that both the shares and pre-funded warrants would be separable immediately from the traditional warrants.

The company also disclosed that it applied for listing of the warrants to trade on NASDAQ under the ticker symbol CLRBZ. The company expects the warrants to trade on or before closing of the public issue. The company expects the public issue to close before April 20 subject to some customary closing conditions.

Following the news, shares of the company were down 31.5 percent on Friday.


Related Articles (CLRB)

View Comments and Join the Discussion!

Posted-In: News Financing Press Releases

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at